InspireMD (Nasdaq:NSPR) announced today that, in consultation with the FDA, it recalled its CGuard Prime 135 cm carotid stent delivery system. The company said it initiated a voluntary recall for the system. After a controlled launch, the company determined that the technical success of the delivery system during carotid artery stenting … [Read more...] about InspireMD recalls CGuard Prime 135 cm stent delivery system in US, gets nod to study neuroprotection tech
Business
AngioDynamics alleges patent infringement by E2 over clot removal technology
AngioDynamics has filed a lawsuit against Endovascular Engineering (E2) in the U.S. District Court for the District of Delaware. Latham, New York-based AngioDynamics alleges that E2 infringes on patents for its AngioVac and AlphaVac blood clot removal systems. AngioVac and AlphaVac, two FDA-approved thrombectomy systems, work to remove blood … [Read more...] about AngioDynamics alleges patent infringement by E2 over clot removal technology
Johnson & Johnson to acquire AtraVerse Medical and its transseptal access system
Johnson & Johnson (NYSE:JNJ) announced today that it entered into a definitive agreement to acquire Atraverse Medical. Atraverse develops the Hotwire transseptal access system, a novel radiofrequency guidewire left-heart access device. It enables zero-exchange left-heart access while acting as a rail for catheter-based therapy systems. … [Read more...] about Johnson & Johnson to acquire AtraVerse Medical and its transseptal access system
Medtronic leads $100M financing for artery denervation tech developer Pulnovo Medical
Pulnovo Medical announced today that it completed an oversubscribed $100 million strategic financing round led by Medtronic. Separate from the financing, the companies entered into a commercial agreement that contemplates potential future commercialization opportunities. Medtronic was joined by existing investors EQT, Qiming Venture Partners, … [Read more...] about Medtronic leads $100M financing for artery denervation tech developer Pulnovo Medical
Stryker makes IVL play with agreement to acquire Amplitude Vascular Systems
Stryker (NYSE:SYK) announced today that it entered into a definitive agreement to acquire Amplitude Vascular Systems (AVS) for an undisclosed amount. Portage, Michigan-based Stryker’s latest strategic move marks its planned entry into the intravascular lithotripsy (IVL) space. IVL remains a hot space, with Johnson & Johnson’s Shockwave … [Read more...] about Stryker makes IVL play with agreement to acquire Amplitude Vascular Systems
Pulse Biosciences names Liane Teplitsky as new COO
Pulse Biosciences (Nasdaq:PLSE) announced today that it appointed Liane Teplitsky as its new COO to further bolster its leadership team. Hayward, California-based Pulse Biosciences also expanded the role of Dr. David Kenigsberg to full-time chief medical officer (CMO). The pulsed field ablation (PFA) technology developer says the appointments … [Read more...] about Pulse Biosciences names Liane Teplitsky as new COO
E2 raises $80M Series C for Hēlo thrombectomy system
Endovascular Engineering (E2) announced today that it raised $80 million in an oversubscribed Series C financing round. Gilde Healthcare and Norwest co-led the latest financing for the Menlo Park, California–based company. Existing investors, including Santé Ventures, 415 Capital, S3 Ventures, Panakès Partners, M&L Healthcare Investments, … [Read more...] about E2 raises $80M Series C for Hēlo thrombectomy system
Catheter Precision looks to sell cardiac EP business, move into aviation
Catheter Precision (NYSE:VTAK) announced that it has engaged a strategic advisor to formally put its cardiac electrophysiology business up for sale. The company expects the marketing process for the business to create shareholder value by monetizing its legacy medical device assets while sharpening focus on its Flyte aviation platform. Fort … [Read more...] about Catheter Precision looks to sell cardiac EP business, move into aviation
Endogenex closes $50M Series C extension to support endoscopic diabetes procedure
Endogenex announced today that it closed a $50 million extension of its Series C financing round. Arboretum Ventures joined as a new lead investor alongside existing investors participating in the round. It builds on the $88 million Series C closed in June 2024, bringing the total round to $138 million. Minneapolis-based Endogenex plans to … [Read more...] about Endogenex closes $50M Series C extension to support endoscopic diabetes procedure
Cook Medical commercially launches two new urology products
Cook Medical commercially launched two new urology products, the Syfonix suction ureteral access sheath and the 7.5 Fr Ascend single-use flexible ureteroscope, according to the company. Syfonix and Ascend are both single-use products used in ureteroscopic kidney stone management procedures and a part of Cook’s larger portfolio of urological … [Read more...] about Cook Medical commercially launches two new urology products
